Cross-border · A De-SPAC advisory operating system

The De-SPAC path: six stages, each one spelled out

A De-SPAC is not a shortcut but a disciplined path. Below, each step is spelled out: what it means commercially, who signs, and what can stop it.

Stage	What it means commercially	Who signs	What can stop it
Readiness	See the gaps honestly before talking valuation	Company & NexaOne	Key materials missing or financials unreliable
Professional team	Securities counsel, PCAOB auditor, registered bank in place	Each licensed professional	No auditor willing to take the engagement
SPAC fit	Shell already public, cash in trust, valuation pre-negotiated	Sponsor & bankers	Terms, promote or timing don't match
LOI / diligence	The company opened up for verification	Counsel & auditors	Diligence finds issues that can't be explained
F-4 / shareholder process	The core registration and disclosure document	Securities counsel (signs)	SEC comments, insufficient disclosure, delay
Closing / public-company ops	Becoming a company that must report continuously	Management & board	Redemptions too high, cash short, weak controls

Jargon, translated into plain business

SPAC shareholders can take their cash back at the deal, reducing money available at closing.

Sponsor economics that may dilute other holders. Model it from the start.

Separately negotiated financing that can fill a cash gap but adds pricing and execution risk.

The core registration and disclosure document often used in a foreign-private-issuer combination; signed by counsel.

Underwriter treatment and related liability under the post-2024 framework; affects how banks participate.

Nasdaq applies higher market-value tests to some markets ($25M/$15M, etc.).

Timelines are illustrative ranges with dependencies, never a promised closing date.

The diagnostic is for education and planning only. It is not an eligibility determination, a securities recommendation, or any guarantee of outcome.